Research ArticleArticle
Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure
Mark C. Genovese, Andrea Rubbert-Roth, Josef S. Smolen, Joel Kremer, Majed Khraishi, Juan Gómez-Reino, Anthony Sebba, Robert Pilson, Sarah Williams and Ronald Van Vollenhoven
The Journal of Rheumatology June 2013, 40 (6) 768-780; DOI: https://doi.org/10.3899/jrheum.120687
Mark C. Genovese
From the Division of Rheumatology, Stanford University Medical Center, Palo Alto, California,
USA; Department of Internal Medicine, University of Cologne, Cologne,
Germany; Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna,
Austria; Center for Rheumatology, Albany Medical College, State University of New York, Albany, New York,
USA; Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador,
Canada; Rheumatology Unit Hospital, Clinical Universitario, Santiago,
Spain; Department of Rheumatology, University of South Florida, Palm Harbor, Florida,
USA; Hoffmann-La Roche Inc., Nutley, New Jersey,
USA; PDBB-Biostatistics, Roche Products Limited, Welwyn Garden City,
UK; and Rheumatology Unit, Department of Medicine, Karolinska University Hospital in Solna, Stockholm,
Sweden.
Andrea Rubbert-Roth
Josef S. Smolen
Joel Kremer
Majed Khraishi
Juan Gómez-Reino
Anthony Sebba
Robert Pilson
Sarah Williams
REFERENCES
- 1.↵
- 2.↵
- Scott DL
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- Genovese MC,
- McKay JD,
- Nasonov EL,
- Mysler EF,
- da Silva NA,
- Alecock E,
- et al.
- 9.↵
- Emery P,
- Keystone E,
- Tony HP,
- Cantagrel A,
- van Vollenhoven R,
- Sanchez A,
- et al.
- 10.↵
- Jones G,
- Sebba A,
- Gu J,
- Lowenstein MB,
- Calvo A,
- Gomez-Reino JJ,
- et al.
- 11.↵
- Kremer JM,
- Blanco R,
- Brzosko S,
- Burgos-Vargas R,
- Halland AM,
- Vernon E,
- et al.
- 12.↵
- Nishimoto N,
- Miyasaka N,
- Yamamoto K,
- Kawai S,
- Takeuchi T,
- Azuma J
- 13.↵
- Schiff MH,
- Kremer JM,
- Jahreis A,
- Vernon E,
- Isaacs JD,
- van Vollenhoven RF
- 14.↵
- Genentech Inc
- 15.↵
- Felson DT,
- Smolen JS,
- Wells G,
- Zhang B,
- van Tuyl LH,
- Funovits J,
- et al.
- 16.↵
- 17.↵
- Solomon DH,
- Karlson EW,
- Rimm EB,
- Cannuscio CC,
- Mandl LA,
- Manson JE,
- et al.
- 18.↵
- Watson DJ,
- Rhodes T,
- Guess HA
- 19.↵
- Solomon DH,
- Goodson NJ,
- Katz JN,
- Weinblatt ME,
- Avorn J,
- Setoguchi S,
- et al.
- 20.↵
- Fransen J,
- van Riel PL
In this issue
The Journal of Rheumatology
Vol. 40, Issue 6
1 Jun 2013
Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure
Mark C. Genovese, Andrea Rubbert-Roth, Josef S. Smolen, Joel Kremer, Majed Khraishi, Juan Gómez-Reino, Anthony Sebba, Robert Pilson, Sarah Williams, Ronald Van Vollenhoven
The Journal of Rheumatology Jun 2013, 40 (6) 768-780; DOI: 10.3899/jrheum.120687
Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure
Mark C. Genovese, Andrea Rubbert-Roth, Josef S. Smolen, Joel Kremer, Majed Khraishi, Juan Gómez-Reino, Anthony Sebba, Robert Pilson, Sarah Williams, Ronald Van Vollenhoven
The Journal of Rheumatology Jun 2013, 40 (6) 768-780; DOI: 10.3899/jrheum.120687